Erin Brodwin is a Health Tech Reporter at Axios. She covers a range of topics including health and wellness, healthcare systems, and the intersection of finance and medicine, with a focus on startups and venture capital in the biotech sector. Erin's work has been featured in prominent publications such as STAT, Yahoo News, Business Insider, and Axios.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Erin Brodwin's coverage heavily focuses on the intersection of technology and healthcare, with emphasis on exclusive reports, citing data, and private sector announcements. She would likely be receptive to pitches that provide unique insights into health tech companies' valuations, M&A activities in the digital health space, or trends in women's health startups.
Given her focus on exclusive reports and data citation, Erin may be interested in receiving pitches from industry experts who can offer insider perspectives or access to proprietary data related to emerging trends in healthcare technologies.
As she doesn't have a specific geographic focus mentioned, it appears that she takes an international view of these topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Hospitals, insurers and other powerful health industry groups
Cancer diagnostics in particular are on on the cusp of transformation.
Anatomy Financial, a digital document lockbox
A growing cadre of brain technology businesses, including Elon Musk's Neuralink, are vying to give people with paralysis command of devices using simply their thoughts.
By: Erin Brodwin
SuperTruth offers its customers the ability to scale with the kind of data imaware houses.
Scripta Insights, a pharmacy management system
Oura looks to be wedging its way into a wearables market dominated by Apple and Google.
The deal is one brick in Commure's growing empire of AI-powered medical tools.
The exploding number of medical scribes intended to solve clinician burnout is causing its own burnout.
Abridge has raised $212.5 million and was valued at $850 million in February 2024.
(833) 317-6278 
